18.03
Schlusskurs vom Vortag:
$17.99
Offen:
$18.005
24-Stunden-Volumen:
533.38K
Relative Volume:
0.45
Marktkapitalisierung:
$4.41B
Einnahmen:
$401.20M
Nettoeinkommen (Verlust:
$-283.01M
KGV:
-12.97
EPS:
-1.39
Netto-Cashflow:
$121.56M
1W Leistung:
-3.79%
1M Leistung:
+6.94%
6M Leistung:
+12.69%
1J Leistung:
-18.16%
Cellebrite Di Ltd Stock (CLBT) Company Profile
Firmenname
Cellebrite Di Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CLBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CLBT
Cellebrite Di Ltd
|
18.03 | 4.40B | 401.20M | -283.01M | 121.56M | -1.39 |
|
MSFT
Microsoft Corporation
|
483.62 | 3.62T | 293.81B | 104.91B | 78.02B | 14.06 |
|
ORCL
Oracle Corp
|
194.91 | 566.61B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
PLTR
Palantir Technologies Inc
|
177.75 | 431.02B | 3.90B | 1.10B | 1.79B | 0.4275 |
|
CRWD
Crowdstrike Holdings Inc
|
468.76 | 119.91B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
469.72 | 90.78B | 7.05B | 1.34B | 1.35B | 8.0234 |
Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-28 | Bestätigt | Needham | Buy |
| 2024-03-13 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2022-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2021-12-02 | Eingeleitet | BofA Securities | Buy |
| 2021-10-21 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Cellebrite Di Ltd Aktie (CLBT) Neueste Nachrichten
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates - sharewise.com
Sell Signal: Why A0VAMV stock remains a top recommendationEarnings Performance Report & Weekly High Conviction Trade Ideas - moha.gov.vn
Cellebrite DI (CLBT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Exploring US High Growth Tech Stocks In December 2025 - simplywall.st
Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Norwood Investment Partners Opens New $4.3 Million Cellebrite Position - AOL.com
Why Cellebrite DI Ltd. (9W9) stock is upgraded to buy2025 Bull vs Bear & Safe Capital Growth Stock Tips - Улправда
Why Cellebrite DI Ltd. stock is in analyst buy zoneEarnings Summary Report & Scalable Portfolio Growth Ideas - Улправда
Is Cellebrite DI Ltd. stock supported by innovation pipelineMarket Activity Summary & Short-Term High Return Ideas - Улправда
Why Cellebrite DI Ltd. stock is seen as undervalued2025 Bull vs Bear & Free Accurate Trade Setup Notifications - Улправда
Will Cellebrite DI Ltd. (9W9) stock recover faster than industryDip Buying & Expert Curated Trade Setups - DonanımHaber
Does Cellebrite DI Ltd. stock trade at a discount to peersRate Cut & Community Trade Idea Sharing Platform - DonanımHaber
Security Tech Check-In: Analyst Insights From 12 Companies Ahead Of The 'Quiet Period' - Sahm
Is Cellebrite DI Ltd. stock attractive for passive investorsMarket Growth Review & Accurate Entry/Exit Alerts - Улправда
Moody National Bank Trust Division Takes $2.67 Million Position in Cellebrite DI Ltd. $CLBT - MarketBeat
Cellebrite DI's (NASDAQ:CLBT) Investors Will Be Pleased With Their Massive 330% Return Over the Last Three Years - 富途牛牛
Cellebrite DI Ltd.'s (NASDAQ:CLBT) Stock Has Shown A Decent Performance: Have Financials A Role To Play? - Yahoo Finance
Why Cellebrite Stock Is Skyrocketing Today - AOL.com
Jump Financial LLC Grows Stock Position in Cellebrite DI Ltd. $CLBT - MarketBeat
Cellebrite Q3 2025 slides: 18% revenue growth amid digital investigation expansion By Investing.com - Investing.com South Africa
Cellebrite DI Stock Price Today | NASDAQ: CLBT Live - Investing.com
Voss Capital LP Increases Stock Holdings in Cellebrite DI Ltd. $CLBT - MarketBeat
869,926 Shares in Cellebrite DI Ltd. $CLBT Acquired by Thematics Asset Management - MarketBeat
Cellebrite DI Ltd. $CLBT Holdings Increased by JPMorgan Chase & Co. - MarketBeat
Cellebrite DI (NasdaqGS:CLBT): Reassessing Valuation After Well‑Received Earnings and Guardian Platform Growth - simplywall.st
Cellebrite: Solid Setup Going Into Next Year (NASDAQ:CLBT) - Seeking Alpha
Cellebrite DI (CLBT) Is Up 8.1% After Q3 Beat And Corellium DealWhat's Changed - simplywall.st
Pertento Partners LLP Raises Stock Holdings in Cellebrite DI Ltd. $CLBT - MarketBeat
Quantbot Technologies LP Increases Position in Cellebrite DI Ltd. $CLBT - MarketBeat
Is Cellebrite DI Ltd. (9W9) stock safe for risk averse investorsJuly 2025 Technicals & Entry Point Strategy Guides - Newser
Officer Shapira Files To Sell 8,448 Of Cellebrite DI Ltd [CLBT] - TradingView
Entry Recap: Why Cellebrite DI Ltd stock is seen as undervalued2025 Buyback Activity & Fast Moving Stock Trade Plans - BỘ NỘI VỤ
Cellebrite DI Ltd. (CLBT): A Bull Case Theory - Insider Monkey
Should I hold or sell Cellebrite DI Ltd. stock in 2025Trade Risk Assessment & Reliable Price Action Trade Plans - Newser
Will Cellebrite DI Ltd. (9W9) stock profit from AI boomJuly 2025 Catalysts & Weekly Chart Analysis and Guides - Newser
Cellebrite DI Ltd. (CLBT): A bull case theory - MSN
Crescent Park Management L.P. Cuts Position in Cellebrite DI Ltd. $CLBT - MarketBeat
What technical patterns form on Cellebrite DI Ltd. (9W9) stock charts2025 Trading Volume Trends & Long-Term Growth Stock Strategies - Newser
How Cellebrite DI Ltd. (9W9) stock compares with market leadersJobs Report & High Accuracy Trade Alerts - Newser
Transcript : Cellebrite DI Ltd. Presents at UBS Global Technology and AI Conference 2025, Dec-02-2025 04 - marketscreener.com
Cellebrite acquires Corellium for $170 million to expand capabilities By Investing.com - Investing.com Australia
Cellebrite completes acquisition of Corellium - TipRanks
Cellebrite DI Completes $170 Million Acquisition of Corellium - marketscreener.com
Cellebrite DI Ltd not updating its Q4 and full-year 2025 outlook at this time - marketscreener.com
Cellebrite Di Ltd Not Updating Its Q4 And Full-Year 2025 Outlook At This Time - TradingView — Track All Markets
Cellebrite Completes Acquisition of Corellium, Enhancing Digital Investigation Platform - TipRanks
Cellebrite acquires Corellium for $170 million to expand capabilities - Investing.com India
Cellebrite Completes Acquisition of Corellium, Extending - GlobeNewswire
Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Cellebrite DI Ltd. (9W9) stock vulnerable to rate hikes2025 Pullback Review & High Yield Equity Trading Tips - BỘ NỘI VỤ
Finanzdaten der Cellebrite Di Ltd-Aktie (CLBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):